Tag: peanut allergy

AR101

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

The company announces their timeline for continued progress toward an FDA approved standardized therapy.
Lia Sommer

Tragedy Averted When Girl Refuses Antihistamine, Demands Epinephrine from School Nurse

Lia Sommer avoided serious complications by demanding the school nurse follow her emergency action plan.
YSPE

Children’s Theater Group Settles Peanut Allergy Discrimination Complaint

Agrees to settlement but admits no wrongdoing.
Patient with Doctor

Study: The Effect of OIT in Severe Milk, Peanut and Egg...

Rest assured, there *is* research being done to determine how immunotherapies can benefit adults.
DNA Helix

Study: Researchers Identify Six Genes Driving Peanut Allergy Reactions

Results represent important step forward for new therapies and treatments.
DBV Patch Closeup

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.
Pediatrician and Baby

Pediatricians Slow to Implement Early Peanut Introduction Guidelines

Only 11% are adequately following the guidelines leaving many at risk of developing peanut allergy later in life.

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.
Peanut Therapy

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.
DBV Patch Closeup

DBV Completes Phase III Study of Peanut Patch

The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.

Connect with Us

29,968FansLike
89FollowersFollow
4,467FollowersFollow
33SubscribersSubscribe